TWIST1 and neoplasm: A plethora of studies reported that siRNAs against TWIST1 delivered by nanoparticles inhibited the EMT process in several tumors, leading to the reduction of tumor progression and metastasis and sensitizing cancer cells to chemotherapy drugs and radiotherapy [83,84,85,86,87,111,112,181,182].